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 Abstract 
In this study we followed the genomic, lipidomic and metabolomic changes associated with 
the selection of miltefosine (MIL) resistance in two clinically derived L. donovani strains 
with different inherent resistance to antimonial drugs (antimony sensitive strain Sb-S; and 
antimony resistant Sb-R). MIL-R was easily induced in both strains using the promastigote-
stage, but a significant increase in MIL-R in the intracellular amastigote compared to the 
corresponding WT did not occur until promastigotes had adapted to 12.2 µM MIL. A variety 
of common and strain-specific genetic changes were discovered in MIL-adapted parasites, 
including deletions at the LdMT transporter gene, single-base mutations and changes in 
somy. The most obvious lipid changes in MIL-R promastigotes occurred to 
phosphatidylcholines and lysophosphatidylcholines and results indicate that the Kennedy 
pathway is involved in MIL resistance. The inherent Sb resistance of the parasite had an 
impact on the changes that occurred in MIL-R parasites, with more genetic changes occurring 
in Sb-R compared to Sb-S parasites. Initial interpretation of the changes identified in this 
study does not support synergies with Sb-R in the mechanisms of MIL resistance, though this 
requires an enhanced understanding of the parasite’s biochemical pathways and how they are 
genetically regulated to be verified fully.  
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 Introduction 
Visceral leishmaniasis (VL, also called kala-azar) is a neglected tropical disease responsible 
for at least 40,000 deaths/year, the majority of which occur in the Indian sub-continent (ISC, 
Alvar et al, 2012). There are a limited number of drugs available for chemotherapy of VL 
and development of drug resistance limits their clinical efficacy (Ready, 2014). 
Understanding the molecular mechanisms responsible for drug resistance may allow (i) the 
development of assays to predict the drug susceptibility of a clinical isolate, (ii) the design of 
interventions to extend the clinical life of a drug and (iii) the guiding of R&D of new drugs.  
 
First-line chemotherapy in the ISC has relied on pentavalent antimonials since 1923 (among 
others, Sodium Stibogluconate or Meglumine Antimoniate). Antimonials have now been 
abandoned in the region because of decreased clinical efficacy and high resistance rates of 
the etiological agent, Leishmania donovani (Ready, 2014). Antimony-resistant (Sb-R) strains 
are still frequently found in patients of the ISC, despite a lower antimonial pressure in the 
region since its replacement by miltefosine (MIL, hexadecylphosphocholine): this could be 
explained by the greater virulence of Sb-R parasites (Vanaerschot et al., 2014). Thus Sb-R 
parasites are more likely to survive in the host and be transmitted to a new host because they 
are more resistant to the effectors of macrophages than Sb-S parasites (Carter et al., 2005, 
Mukhopadhyay et al., 2011; Mukherjee et al., 2013; Guha et al., 2014; Vanaerschot et al., 
2014). MIL was registered in India in 2002 and it is the first oral drug for VL treatment. It is 
one of the main pillars of the current kala-azar elimination programme that aims to reduce the 
incidence of the disease in the ISC to lower than one case per 10,000 individuals at district or 
sub-district levels by 2015 (WHO-SEARO, 2011). After ten years of use, the efficacy of MIL 
is decreasing in India (Sundar et al., 2012) and Nepal (Rijal et al., 2013). Fully MIL-resistant 
(MIL-R) strains have not yet been encountered in the ISC (Rijal et al., 2013, Prajapati et al., 
2013) but this is probably only a matter of time, as parasites with varying MIL 
susceptibilities have been reported (Bhandari et al., 2012).  
 
In the absence of MIL-R clinical isolates, the primary way to study the mechanisms of 
resistance and to find molecular markers is through experimental selection. Previous reports 
showed that Leishmania rapidly develop MIL resistance in experimental conditions (Perez-
Victoria et al., 2003) and that it was associated with a decreased accumulation of the drug. 
Two mechanisms were involved: (i) an increased drug efflux mediated by the overexpression 
of an ATP-binding cassette (ABC) transporter P-glycoprotein (LdBPK_341060, ABCB4), 
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 and (ii) a decreased uptake through the inactivation of a P-type ATPase, the MIL transporter 
LdMT (LdBPK_131590) and its beta subunit LdRos3 (Perez-Victoria et al., 2006). More 
recently, a series of high-throughput molecular screening methods were applied to scrutinise 
adaptations developed in selected MIL-R parasites. Genomic analysis of MIL-R Leishmania 
major confirmed the importance of the P-type ATPase and identified mutations in other 
genes (Coelho et al., 2012). In another study, RNA microarray investigation detected many 
differentially expressed genes in MIL-R L. donovani, highlighting a compromised DNA 
replication/repair mechanism, reduced protein synthesis and degradation, increased drug 
efflux, altered energy utilization and increased antioxidant defence mechanisms (Kulshrestha 
et al., 2014). Finally, the metabolomic analysis of an Ethiopian MIL-R L. donovani strain 
highlighted an increase in the levels of amino acids, possibly to promote the adaptation of 
MIL-R strains in the macrophage (Canuto et al., 2014).  
 
Earlier work on MIL-resistance has focused on laboratory strains sampled from patients 
decades ago. This does not take into account previous adaptations to other drugs, in particular 
antimonials, which have exerted continuous selective pressure on natural populations of L. 
donovani in the ISC since 1923 (Downing et al., 2011 and Decuypere et al., 2012). 
Consequently, we experimentally selected MIL-resistance in an Sb-R and Sb-S L. donovani 
strain recently derived from clinical isolates of Nepalese patients. In order to 
comprehensively evaluate the underlying mechanisms associated with resistance to MIL, we 
compared the genome, metabolome and lipidome of wild-type (WT) strains and lines 
gradually adapted to MIL.  
 
Results 
Genomic differences between WT Sb-S and Sb-R strains prior to miltefosine exposure 
High-depth genome sequence data allowed the identification of key genomic differences 
between the two wild type (WT, summarised in Table 1) L. donovani isolates prior to 
adaption to MIL (further referred to as WT Sb-R and WT Sb-S). Some of these were 
potentially associated with antimonial resistance in the Sb-R. Firstly, eight changes in 
chromosome copy number distinguished the pair: the WT Sb-R had a higher dose of 
chromosomes 2, 8, 11, 14 and 33 and a lower copy number of chromosomes 5, 26 and 35 
(Table S2). Secondly, there were 127 SNPs between the two isolates (Table S3), including 33 
non-synonymous single-nucleotide polymorphisms (SNPs, Table S4A), of which ten were 
previously associated with Sb-R in the ISC (Downing et al., 2011). Thirdly, 16 loci had a 
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 local copy number variation (CNV), affecting 30 genes and 3 non-coding regions (Table 
S4B). Fourthly, 38 deletions and 13 insertions differentiated the pair, including a deletion in 
the WT Sb-R of two bases at the AQP1 gene (aquaglyceroporin 1, LdBPK_310030, Table 
S4C). 
 
Differences in metabolite and lipid profile between WT strains prior to miltefosine 
exposure  
Approximately 350 metabolites were annotated with IDEOM, 14 of them significantly 
different between the two WT strains (summarised in Table 2, p value < 0.05). These 
metabolites were associated with different metabolic pathways including protein production, 
lipid metabolism and synthesis of DNA. Over 400 lipids were seen in promastigote samples 
but only 21 were significantly different between the two strains (p < 0.05, Table S6). Sb-S 
WT promastigotes had significantly higher levels of ten phosphatidylcholines (PC) and 
significantly higher levels of two lyso-PC (LPC) lipids as peaks corresponding to LPC (19:0) 
and LPC (24:0) were consistently identified in the Sb-S strain but were absent in the Sb-R 
strain. The Sb-R WT strain had significantly higher levels of eight PCs. All of the PCs 
upregulated in the Sb-R strain were unsaturated, with five or more c-c double bonds in the 
tail groups. 
 
Exposure to MIL produces highly resistant L. donovani parasites 
Selection of WT promastigotes that were resistant to the highest concentration of MIL tested 
(74 µM) took 31 weeks. Both WT strains took similar lengths of time to adapt to the highest 
concentration of MIL. The susceptibility of the MIL-R parasites was tested against the 
intracellular amastigote stage using infected macrophages throughout the experiment to 
determine if MIL-R selection at the promastigote stage was conveyed to the intracellular 
amastigote stage. For both Sb-S and Sb-R strains, the IC50 values of amastigotes did not 
increase compared to the corresponding WT until promastigotes tolerated 12.2 µM MIL 
(Table 3). The fully resistant promastigotes (74 µM) were also clearly resistant at the 
amastigote stage, with an IC50 of 44 µM (15 times the value of WT) and 35 µM (13 times the 
value of WT) for the Sb-S MIL-R and Sb-R strain MIL-R, respectively (Table 3). Increasing 
the drug concentration to select MIL-R promastigotes from 49.2 to 74 µM did not result in a 
corresponding increase in the IC50 at the amastigote stage (Table 3).  The fact that Sb-S MIL-
R and Sb-R MIL-R parental promastigotes had IC50 values that were higher than the 
maximum MIL concentration used to induce resistance was not unexpected, as all two MIL-
Page 7 of 43 Molecular Microbiology
This article is protected by copyright. All rights reserved.
 R clones were grown in the medium containing 74 µM MIL. An example of the data obtained 
is shown in Figures 1A-B (promastigotes of Sb-R and Sb-S strains) and Figure 1C 
(amastigotes of Sb-R strain). 
  
The Sb-S MIL-R and Sb-R MIL-R promastigotes adapted to 74 µM were then cloned to 
determine if the clones had the same MIL susceptibility as the MIL-R parent line. These 
clones had MIL IC50 values that were lower than the corresponding MIL-R parent. This 
indicated that selection resulted in a mixed population of parasites with different 
susceptibilities to MIL (Table 2). The clones with the highest resistance to MIL for both 
strains (clone 8 for the Sb-S MIL-R strain, clone 9 for the Sb-R MIL-R strain) were then 
tested for their susceptibility to MIL as intramacrophage amastigotes using in vitro infected 
macrophages. The IC50 value of the Sb-S MIL-R parent and its clone were similar, and 
removal of MIL pressure for 2 weeks of culture did not alter the MIL susceptibility of the 
MIL Sb-S MIL-R cloned parasite.  In contrast,  the cloned Sb-R MIL-R parasite had a 
slightly higher IC50 compared to its parent,  and culturing the cloned parasite in the absence 
of MIL resulted in a drop in MIL susceptibility of the cloned parasite to the Sb-R MIL-R 
parent range. Selection of MIL-R did not impact on Sb susceptibility as the Sb-R MIL-R 
clone 9 gave a similar dose-response to SSG treatment as the WT Sb-R parasite (Fig. 1D).  
 
Genomic changes during MIL-R selection 
The type of strain-specfic and common genetic changes that occurred after MIL 
adaption of the two strains are summarized in Table 1.  
a) Mutated loci common to both strains  
Upon selection of MIL-R, the most significant change shared between the Sb-S and Sb-R was 
of the LdMT locus on chr13 (LdBPK_131590, Table S7-S8). In addition to a decrease in the 
copy number of chr13 (Table 1, Fig. 2A and B), there were three different mutations at this 
gene: one in the Sb-R and two in the Sb-S. The Sb-R one (E197D) was observed at 35 µM 
MIL and was present in all cells by that stage, despite only emerging at 12.2 µM. 
Surprisingly, two independent LdMT variants were discovered in the Sb-S MIL-R line: a 
deletion (∆LdMT) and a SNP (A691P); Figure 2B shows the evolution of these variants 
during the selection process. At 3 µM, the 8.86 kb deletion of bases 621,000 to 629,860 
encompassing two genes (LdBPK_131590, the LdMT locus at positions 622,408-625,701 
and LdBPK_131600, at positions 627,613-629,076) was found and it gradually increased in 
frequency within the population from 7% (3 µM MIL) to 27% (6 µM) to 44% (12.2 µM) to 
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 71% (35 µM). A691P was first observed in the Sb-S parasite cell population at 12.2 µM MIL 
with a frequency of 16%, indicating at this stage 36% of the Sb-S population still survived 
with the WT LdMT allele (apart from a reduced chr13 copy number) assuming 10 
generations/step. By 35 µM, only 2% of the Sb-S population did not have a mutant LdMT, 
indicating that a WT LdMT was not viable at this level of toxicity. The fall in population 
frequency of ∆LdMT from 71% (35 µM) to 33% (49 µM) and 29% (61 µM) was paralleled 
by a corresponding jump in LdMT-A691P (62% at 49 µM and 67% at 61 µM, respectively). 
This suggested that A691P was more advantageous at higher concentrations of MIL than the 
deletion, perhaps due to deleting an unannotated adjacent gene (LdBPK_131600, at 627,613-
629,076) or because some unknown function of LdMT may be preserved by the A691P 
substitution. Subsequent passaging in the absence of drug pressure increased the frequency of 
the deletion (∆LdMT, 0.86) and the sensitive allele (LdMT-A691; 0.04) relative to the 
resistant LdMT-P691 (0.10). Sequence alignments showed that the ∆LdMT region adjoining 
LdBPK_131590 and LdBPK_131600 was flanked by two 444-bp direct repeats (Fig. 2C).  
  
Changes in mutation frequencies over time during the selection process were used to infer the 
relative importance of the different MIL-R mutations using a mathematical model. The 
evolutionary history of mutations already implicated in MIL-R indicated that mutations at the 
LdMT gene were beneficial with a selective advantage of 17% for the deletion and 26% for 
the A691P allele in Sb-S. No significant deviations from a neutral model were observed for 
the other MIL-R mutations. Our model predicted that the LdMT deletion was pre-existing in 
the Sb-S cell population at a frequency of close to 1% (Fig. S1). By contrast, A691P was 
inferred to have a frequency < 0.02% in the initial population, suggesting that this could be a 
de novo mutation. Changes in copy number also appear to drive adaptation to MIL (Table 
S9). 
  
The deletion of LdMT was verified by PCR using genomic DNA prepared from Sb-S MIL-R 
clone 8 and Sb-R MIL-R clone 9 promastigotes, and a PCR product was only detected with 
the latter (data not shown). LdMT expression was verified in WT Sb-R and Sb-R MIL-R 
promastigotes by quantitative RT-PCR. LdMT transcripts were present in the WT Sb-R but 
not in the Sb-R MIL-R clone 9, while both samples showed alpha tubulin transcripts (Ct 
values for WT Sb-R, Sb-R MIL-R and negative controls, respectively; (i) for alpha-tubulin: 
24.07 ± 0.28;  27.19 ± 0.84; 35.01 ± 0.94 and (ii) for LdMT: 27.37 ± 0.36; >35. We verified 
in the Illumina alignments if SNPs were present in the UTRs flanking LdBPK_131590 and 
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 did not find any: the next SNP was a synonymous C/A transition at position 575518 of gene  
LdBPK_131610 (position corresponds to new draft reference genome after PacBio  
sequencing, unpublished data; it corresponds to position 631021 in the current reference  
genome).   
   
b) MIL-selected changes specific to different backgrounds  
All the genomic differences observed at the onset of the study between the WT Sb-S and Sb- 
R strains remained upon MIL-R selection, except the somy of 5 chromosomes (2, 8, 14, 33  
and 35, summarised in Table 1). For each sample, a series of specific variants appeared  
during the selection (Text S1 and S2). When comparing the Sb-S MIL-R strain to its WT  
counterpart, somy was altered in 4 chromosomes (increase of Chr6, 14 and 23 and decrease  
of Chr33, Table S2), there were 17 heterozygous SNPs (Table S7) and 10 CNVs (Table S10)  
– the sole homozygous SNP was A691P. For the Sb-R MIL-R vs WT comparison, somy was  
also altered for 4 chromosomes (decrease in Chr2 and 8, increase in Chr9 and 35, Table S2),  
there were 6 homozygous SNPs (including E197D), 7 heterozygous ones (Table S8), and 10  
CNVs (Table S10). Interestingly, all CNVs observed in the Sb-S MIL-R strain corresponded  
to single CDS, while 4 of the CNVs of the Sb-R MIL-R strain corresponded to large  
fragments of chromosomes (amplification of 49,735 bp in Chr27, spanning a whole  
transcription unit; deletion of 116,778 bp in Chr 31; two deletions of 307,617 bp and 674,372  
bp respectively in Chr35) containing a total of 298 CDS (Tables 1 and S10).   
  
MIL transporter mutations are likely to prevent phospholipid transport  
A variety of mechanisms could be responsible for the higher resistance of MIL-adapted  
parasites compared to the corresponding WT. One is reduced drug uptake by the MIL  
adapted parasites compared to the WT. To explore this, we initially monitored MIL levels in  
Sb-R WT and Sb-R MIL promastigotes exposed to MIL. We found that it was only possible  
to determine drug levels up to two hours post-treatment as WT parasites began to show signs  
of cell death after two hours, resulting in smaller number of parasites being present. We then  
compared MIL levels in drug exposed Sb-S WT and Sb-R WT promastigotes and their MIL  
resistant parasites.  MIL concentrations were significantly lower in the MIL-R promastigotes  
compared to the corresponding WT parasites (P < 0.05) at all times points, indicating that  
MIL uptake was minimal or even non-existent in MIL-R parasites (Fig. 3).   
  
Metabolomic changes during MIL-R selection  
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 Twenty-three metabolites were significantly altered in the Sb-S MIL-R clone compared to the 
Sb-S WT parent and in all cases adaptation to MIL was associated with an up regulation in 
the metabolites (p < 0.05, Tables 2 and S11). In contrast only 12 metabolites were 
significantly different in Sb-R MIL-R clone compared to the Sb-R WT, with 9 being 
upregulated and 3 being down regulated compared to the WT (Table S11). Inspection of the 
metabolites altered in the Sb-S and Sb-R strains (Table S5) and their corresponding MIL 
adapted strains (Table S11) indicates that differences in the metabolites was not simply due 
to existing differences in the metabolites present in the WT strains.   
Nine metabolites involved in lipid metabolism were found to be the affected by selection of 
MIL resistance between the two strains. Six of these are involved in the Kennedy pathway 
(Fig.4), the primary metabolic pathway for the synthesis of phosphatidylcholines (PC) and 
phosphatidylethanolamines (PE). Only three of the significantly altered metabolites were 
common to both MIL-R clones i.e. choline-phosphate, phosphodimethylethanolamine (both 
involved in the Kennedy pathway) and stearoylglycerone phosphate, and they were all 
upregulated.  
 
Lipidomic changes during the MIL-R selection 
Selection of MIL-R was associated with significant differences in lipid content compared to 
the corresponding WT parent but these were restricted to PC and LPC lipids (summarised in 
Table 2), and alterations in the composition of PE lipids (data not shown). Four LPCs were 
significantly upregulated in the Sb-S MIL-R strain compared to its WT. Three LPCs were 
upregulated in the Sb-R MIL-R strain compared to its WT, and two were down regulated 
(Table S13). Two of these altered LPCs were common to both MIL-R strains [LPC(16:00) 
and LPC(18:0)], and in both cases the corresponding LPC was upregulated compared to the 
respective WT.  
 
Eleven PCs were found in significantly higher amounts between the Sb-S MIL-R strain and 
its WT, with six having a ratio of >2.0. In sharp contrast, all ten PC were downregulated in 
the Sb-R MIL-R strain compared to its WT (Table S13). None of the altered PCs were 
common to the two MIL-R strains (Table S13).  Only five PCs altered in the MIL-R strains 
were significantly different between the two WT strains (compare Tables S6 and S13). Three 
PCs were significantly higher in the WT Sb-S strain compared to the WT Sb-R strain 
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 [PC(32:0), PC(33:0), PC(35:0)] and MIL-R selection further increased this difference. All of 
the PCs found to differ between Sb-S MIL-R and WT were downregulated, long chain PCs 
and highly unsaturated (at least 39 carbons in the side chains and 4 to 10 carbon double 
bonds).  In contrast, all PCs significantly different in Sb-R MIL-R were upregulated and were 
either saturated or had only a small number of carbon double bonds (maximum of 4). 
   
Phosphodimethylethanolamines (PEs), diacyl-glycerols (DAGs), triacyl-glycerols (TAGs), 
sphingolipids (SLs) and other minor lipid classes were analysed for alterations occuring as a 
result of MIL-R. Of these, only SLs of Sb-R MIL-R were found to differ significantly 
compared to the corresponding WT. Of the sphingolipids identified in the Sb-R WT and 
MIL-R lines, 15 were consistently downregulated in the Sb-R MIL-R compared to Sb-R WT 
(p < 0.05, Table S14). Of these, eight were different species of sphingomyelins and five were 
ceramides. Similar levels of these lipids were present in Sb-S and Sb-R WTs, indicating that 
the significant changes in these lipids were specific to the Sb-R MIL-R.   
Discussion 
We performed a stepwise selection of miltefosine (MIL) resistance in WT Sb-S 
(BPK282/0cl4) and Sb-R (BPK275/0cl18) strains derived from recent clinical isolates from 
Nepal.  In the study, amastigote and promastigote MIL sensitivities together with lipidomic, 
metabolomic and genomic changes possibly associated with MIL-resistance (MIL-R) were 
assessed to explore a possible impact of Sb susceptibility background on the development of 
MIL-R. This study represents the first time such a comprehensive biochemical and genomic 
screening has been performed, and it allowed molecular differences associated with 
adaptation to MIL to be linked to mutational changes and changes in lipid and metabolite 
profile within the two strains. In our study we focused our molecular analyses on the 
promastigote stage rather than the clinically relevant amastigotes, for several reasons. It was 
impossible so far to select MIL-R in amastigotes of L.donovani (Hendrickx et al., 2014); in 
contrast, in promastigotes, it is rather easy and as demonstrated here, the MIL-R phenotype is 
preserved in derived amastigotes. In addition, it is difficult to extract host-free amastigotes 
from in vitro or in vivo infected macrophages and the purification and extraction processes 
may lead to changes in lipid or metabolite profiles compared to what occurs in situ. Results 
from untargeted studies such as this study using promastigotes can be used in the future to 
guide targeted studies in amastigotes.  
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 During the selection experiment, we generated parental lines with 28 to 57 times decreased  
susceptibility to MIL as promastigotes, while decrease was around 13 to 15 times in the  
amastigote stages. A significant increase in the IC50 value for the intramacrophage amastigote  
stage was not apparent until parasites adapted to survive in 12.2 µM MIL. Studies on the  
pharmacokinetics of MIL indicate that blood levels above this concentration should be  
achieved, for example treatment with MIL at 100 mg/kg for 28 days resulted in maximal  
median concentration of 70 µg/ml (172 µM) on day 23 (Dorlo et al., 2012). However blood  
levels may not be indicative of MIL levels within the macrophage and more recent studies  
have indicated that MIL treatment failures are due to limited drug exposure in patients (Dorlo  
et al., 2014) rather than MIL-R in the parasite population. We observed considerable  
cytotoxicity in macrophages treated with 148 µM MIL, indicating that this concentration  
would be very cytotoxic if it is maintained in vivo after dosing. Therefore intracellular levels  
are likely to be much lower than 172 µM. Thus, intracellular parasites within the  
parasitophorous vacuole of infected macrophages may have limited exposure to high  
concentrations of MIL, and this may explain why it has proved difficult to show increased  
IC50 values in parasites recovered from patients that relapse after MIL treatment (Rijal et al.,  
2013).   
  
Clones derived from the parental MIL-R lines were also resistant to the drug, albeit at  
variable degrees, hereby supporting the polyclonal nature of a resistant population with  
individual cells with varying susceptibilities (Coelho et al., 2012). Our results also  
demonstrated that the main mechanism responsible for the resistance of our lines was a low  
accumulation of the drug in MIL-R parasites. Previous studies showed that this phenomenon  
can be associated with lower inflow of higher efflux, through alterations of the P-type  
ATPase LdMT and/or its beta sub-unit, LdRos3 (Perez-Victoria et al., 2003 and 2006) or  
over-expression of ABC-transporters (Castanys-Munoz et al., 2008). From a genomic point  
of view, our results converged on alterations of LdMT in both Sb-S and Sb-R strains, and no  
other miltefosine-driven changes were detected. Different types of mutations were observed,  
including non-synonymous SNPs at different positions of LdMT, complete deletion of the  
gene, and changes in the copy number of chromosome 13 containing LdMT. Interestingly,  
the first genomic adaptation during selection was the early (< 12.2 µM MIL) shift of  
chromosome 13 from trisomy to disomy in both Sb-S and Sb-R. Aneuploidy is a major  
feature of L. donovani genetic variation (Downing et al., 2011, Mannaert et al.,  2012) and  
the ability to alter the chromosome copy number may be a simple mechanism to respond  
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 quickly to selection pressures, perhaps acting as transitional intermediate fitness state until 
more beneficial mutations have occurred (Covert et al., 2013). 
 
Loss-of-function mutations are common in drug resistant parasites (Ashley et al., 2014) and 
this loss of gene function can offer a path to rapid adaptation to environmental stresses (Khan 
et al., 2011). Deletion of LdMT was observed in the Sb-S strain only with a changing 
frequency during the selection process relative to alternative SNP alleles within the 
population of cells. LdMT was deleted together with a gene encoding a hypothetical protein 
(LdBPK_131600) and deep analysis of the sequence revealed that the locus containing the 
two genes was flanked by two 444-bp direct repeats. Such repeats are abundant in the 
Leishmania genome and by homologous recombination they can lead to amplification or 
deletion of the corresponding loci (Ubeda et al., 2014). Mathematical modeling showed a 
selective advantage for the deletion in the Sb-S strain, but the advantage was higher for the 
A691P SNP. With respect to SNPs, there is no evident pattern in the LdMT mutations’ 
position on the protein internal or external portion, effect on protein hydrophobicity, 
proximity to transmembrane domains (Tables S15-17), or local domain type (Text S3). Last 
but not least, we did not detect transcripts of LdMT in the Sb-R MIL-R strain. This type of 
phenomenon is generally associated with mutations in the regulatory regions flanking the 
gene of interest and in present case, the only SNP was within the CDS itself (E197D) and the 
closest one was a C/A transition in the second next gene (LdBPK_131610). Such a result is 
rather unexpected, but is similar to studies in trypanosomes where a loss of heterozygocity at 
the TbAT1 locus accompanied loss of expression (Stewart et al., 2010).   
 
From a metabolomic point of view, a few metabolites showed similar changes in both MIL-R 
strains. Three of them were amino acids, class of metabolites previously reported to be 
altered in different types of drug-resistant L.donovani lines in which they were associated 
with protection against oxidative stress (Berg et al., 2013 and 2015). One of which was 
proline, which is also associated with protection against oxidative stress (Inbar et al., 2014). 
Another class of metabolites deserves particular attention, i.e. those involved in lipid 
metabolism. More specifically, the Kennedy pathway, the primary metabolic pathway for the 
synthesis of phosphatidylcholines (PCs) and phosphatidylethanolamines (PEs) in L. donovani 
(Kennedy and Weiss, 1956), appeared to be significantly modulated upon resistance to MIL. 
While different metabolites of the Kennedy pathway were found to be modulated in both 
MIL-R strains, two of them were common, namely choline-phosphate and 
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 phosphodimethylethanolamine. Consistent with this finding, the lipid content of MIL-R  
parasites was altered compared to their WT, with PCs and LPCs being mostly affected. Four  
LPCs and 11 PCs were upregulated in Sb-S MIL-R compared to its WT, and 8 of the PCs had  
between 1 and 4 double bonds in the fatty acid tails. In contrast, most lipids were  
downregulated in the Sb-R MIL-R compared to its WT, their PCs were polyunsaturated and  
had relatively long chain tails.  This indicated that the antimony susceptibility background of  
the strains did have an impact on the adaptation shown by the parasites. Previous studies have  
highlighted an altered lipid metabolism in MIL-R parasites and MIL treatment has been  
associated with a decrease in PC content in tandem with an increase in PE content.  
(Rakotomanga et al., 2007; Imbert et al., 2012). This is somewhat correlated with our Sb-R  
MIL-R clone in so far as a decrease in PCs are observed. However a significant increase in  
PC content was the most notable change in the lipid pool for the Sb-S MIL-R. This  
inconsistency may reflect the difference in the genetic background of the parasites.  
Rakotomanga and Imbert’s studies used strain LV9 [MHOM/LV9/HU3] from Ethiopia  
whereas clinical isolates from Nepalese VL patients were used in this study. The  
compositions of lipids in the parasite membrane are known to have a significant effect on the  
membrane fluidity (Berg et al., 2013 and 2015). Increasing the chain length or saturation of  
fatty acid tails can also effect membrane fluidity and increase resistance to oxidative stress,  
making the parasites even better at tolerating exposure with reactive oxygen species within  
the host macrophage (Zhang and Beverly 2010). Sphingolipid metabolism was also  
significantly reduced in Sb-R MIL-R. Given that SLs are a major source of ethanolamine  
phosphate in the Kennedy pathway, it would be logical to see a knock on effect in the PE  
content. While the total PE content of Sb-R MIL-R appeared unaffected, the composition of  
the lipid anchors altered with a significant increase in PEs with diacyl lipid anchors. PEs can  
be synthesised via headgroup exchange with PCs, and the significant decrease of diacyl-PCs  
in Sb-R MIL-R compared to Sb-R WT could be due to conversion of these PCs to PEs, which  
would explain the reduction in SL metabolism in Sb-R MIL-R.   
  
This study identified a number of genetic, lipidomic and metabolomic changes during MIL  
adaptation in two recent clinical isolates with differing prior sensitivities to antimonials. Both  
isolate types adapted at similar rates to MIL and could tolerate it at comparable levels. This  
study highlighted that both shared a two-tiered genetic response, first altering chromosome  
copy number and second mutating the LdMT gene when more MIL was added. These  
changes were paralleled by metabolic and lipid ones focused on the Kennedy pathway. More  
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 metabolite changes occurred in the Sb-S strain compared to the Sb-R one, suggesting that Sb-
R was associated with a faster development of MIL-R. However, the picture was different 
from a genomic point of view, specifically at CNV level (298 in the Sb-R MIL-R strain vs 8 
only in the Sb-S MIL-R one, Table 1). We found initial evidence that antimonial resistance 
does not provide immediate faster adaptations to high doses of MIL. Future studies should 
address the lack of knowledge of the biochemical pathways of Leishmania and their 
regulation to improve understanding of the molecular mechanisms responsible for MIL 
resistance. Our study focused on two isolates but we have identified key metabolites, lipids 
and genetic changes for future studies using more strains. In addition supplementing the 
medium with radiolabelled precursors (Millerioux et al., 2013) and subsequent identification 
of metabolite/lipid products in the Kennedy pathway, would allow more detailed analysis of 
the impact of MIL-R on the parasite’s biochemistry.  
 
Experimental procedures 
Materials 
Miltefosine (MIL) was kindly provided by WHO-TDR. Resazurin, Giemsa stain, were 
purchased from Sigma-Aldrich (Gillingham, UK). HOMEM medium (custom made by 
Invitrogen, Paisley UK), RPMI-1640, penicillin/streptomycin, glycine and foetal calf serum 
were obtained from Invitrogen, Paisley, UK. All organic solvents (acetonitrile, isopropanol, 
methanol, chloroform) were HPLC grade (Fisher Scientific, Loughborough, UK). 
Ammonium formate was HPLC grade (17843, Sigma-Aldrich Company Ltd., Gillingham, 
UK) and mass spectroscopy vials (KVP6112) fitted with a low-volume insert (INSF-01) were 
purchased from Kinesis Ltd (St Neots, UK). Isolation of DNA and RNA was performed 
using DNeasy Blood & Tissue kit or RNeasy Mini kit respectively, purchased from Qiagen, 
(Crawley, UK) and cDNA synthesis was performed using AffinityScript Multiple 
Temperature Reverse Transcriptase (Stratagene/Agilent Technologies, Wokingham, UK). 
Random Primers (Bioline Reagents, London, UK). MyTaq DNA polymerase reagents 
(Bioline Reagents) were used for all standard PCR reactions. Real Time PCR reactions were 
performed using SYBRgreen Master Mix (Abgene/Thermo Scientific, Loughborough, UK). 
 
Animals and parasites 
Age matched inbred BALB/c female mice (20-25 g) in-house bred were used in studies at 
Strathclyde University. Animal studies were carried out with local ethical approval and had 
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 UK Home Office approval.  We used two clones derived from Nepalese clinical isolates and 
previously tested for their SSG susceptibility (Rijal et al., 2007): 
MHOM/NP/03/BPK282/0cl4 (designated Sb-S, based on its sensitivity to SbV and SbIII)  and 
MHOM/NP/03/BPK275/0cl18 (designated Sb-R, based on its relative insensitivity to SbV and 
SbIII). Both parasites are representative of main populations circulating in the ISC. 
 
Selection of miltefosine resistant (MIL-R) clones  
Selection was done on the promastigote stage: L. donovani Sb-S and Sb-R strains were 
adapted to grow in increasing concentrations in a step-wise manner with MIL (3, 6, 12.2, 35, 
49.2, 61 µM and 74 µM) until all lines grew at similar rates as wild-type parasites in 
HOMEM medium supplemented with 20% foetal calf serum. Promastigote resistance to MIL 
was stopped at 74 µM because of toxicity for macrophages at higher concentrations. Clones 
derived from the MIL-R lines were isolated using a micro-drop method (Van Meirvenne et 
al., 1975), and expanded in Tobie’s medium and then passaged using HOMEM medium 
supplemented with 20% (v/v) foetal calf serum.  A stock solution of aqueous MIL (3 mg/ml, 
freshly prepared every 3 months) was stored at 4°C was used to prepare drug selection 
medium.   
 
Lipidomic/metabolomic studies 
Extraction of lipids or metabolites was carried out on day 4 of culture. Prior to extraction all 
of the biological replicate cultures were quenched to 0oC in an ethanol-dry ice bath to halt 
metabolism. For each strain, four aliquots, from four separate cultures, containing 4 x 107 
promastigotes, were pipetted into pre-chilled eppendorf tubes which were kept at 0oC 
throughout the extraction procedure. The aliquots were centrifuged for 3 minutes at 2,700 x g 
and the supernatant was removed as spent medium for later analysis. The promastigotes were 
then washed by re-suspending them in 1 mL of PBS, pre-chilled to 0oC. They were then 
centrifuged at 2,700 x g for 3 minutes and the supernatant was removed. This washing 
procedure was repeated three times. After washing the parasites were resuspended in 200 µL 
of methanol and chloroform (1:1 v/v for lipid extraction) or chloroform:methanol:water 
mixture (20:60:20 v/v for metabolite extraction)  and shaken in a thermomixer for 1 hour at 
1400 rpm, 0oC. The tubes were then centrifuged for 2,700 x g for 3 minutes at 0oC and the 
resulting supernatant was removed and transferred to a mass spectrometry vial fitted with a 
low-volume insert. Samples were stored at -70oC until analysed. 
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 Lipidomic and metabolomic samples were analysed using a Dionex Ultimate 3000 HPLC 
system (Thermo Fisher Scientific Inc., Waltham, USA). A silica gel column (150mm x 3mm 
x 3µm, HiChrom, Reading, UK) was used for lipidomic analysis and a ZIC-pHILIC column 
(150mm x 2.1mm x 5µm, Merck, Darmstadt, Germany) was used for metabolomic analysis.  
The columns were connected to a Thermo Scientific Exactive Mass Spectrometer (Thermo 
Fisher Scientific Inc., Waltham, USA) running in positive/negative scanning mode. In 
lipidomic analysis two solvents were used in separation (solvent A: 20% isopropyl alcohol 
(IPA): 80% acetonitrile; solvent B: 20% IPA: 80% ammonium formate [20 mM]) using 
gradient elution at a flow of 0.3 mL/min (0-1 min 8% B, 5 min 9% B, 10 min 20% B, 16 min 
25% B, 23 min 35% B, 26-40 min 8% B).  In metabolomic studies different solvents were 
used in separation (solvent A: 20mM ammonium carbonate adjusted to pH 9.2 with 
ammonia; solvent B: 100% acetonitrile). Gradient elution at a flow rate of 0.3 mL/min was 
used (0 min 80% B, 30 min 20% B, 31 min 8% B, 36 min 8% B, 37 min 80% B, 46 min 80% 
B).   Processing of metabolite and lipid data was performed as detailed in (t'Kindt et al., 
2010). Briefly, raw data files produced by the Exactive mass spectrometer were converted to 
mxXML format and centroided using MSConvert (Proteowizard, 
http://proteowizard.sourceforge.net/downloads.shtml). Individual peaks were picked based on 
non-linear retention time alignment, feature detection and feature alignment using the 
centwave method from XCMS (https://metlin.scripps.edu/xcms/). These peaks were 
converted to .peakML files using MzMatch.R (http://mzmatch.sourceforge.net/ index.php). 
MzMatch.R was then used for peak extraction, filtering, normalisation, group filtering and 
gap-filling of peaks. This produced a single file in ‘.text ‘ format containing peak groups with 
the same mass/charge (m/z) values from the different biological replicates. This file was then 
converted to a .txt file and m/z values were identified as specific lipids using Xcalibur and an 
in-house Excel macro that calculated the total number of carbons and saturated carbon bonds 
in the fatty acid tails of each lipid class. Metabolites were identified using IDEOM (Creek 
Barrett, 2014) and 4 standard mixes were used in assays. The software identified 
metabolites/lipids that were significantly different between treatments. Comparisons between 
groups were based on the ratio of WT/WT or MIL-R/WT, using the mean ratio for the 
respectively WT used as comparator. 
 
Genome sequencing and variant screening 
Genomic DNA was sheared into 400–600-base pair fragments by focused ultrasonication 
(Covaris Adaptive Focused Acoustics technology, AFA Inc., Woburn, USA) and standard 
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 Illumina libraries were prepared. 100 base pair paired end reads were generated on the HiSeq 
2000 according to the manufacturer’s standard sequencing protocol (Bonner et al., 2009) to 
produce an average of 55.4-fold read coverage per site with at least 21-fold median depth for 
each sample (Table S1). ENA SRA accession numbers for all sequencing libraries are listed 
in Table S1. The DNA reads were screened for contamination, PCR duplicate were removed, 
and those with insert sizes <1,000 bases were mapped using Smalt with exhaustive 
alignments (version 0.7.2 www.sanger.ac.uk/resources/software/smalt/, Ponstingl and Ning, 
2010). Non-mapping reads, low quality bases, bases in repetitive regions, bases with poor 
mapping scores, bases in low-complexity regions and bases with low read coverage were all 
excluded from analysis. Bases with significant forward-reverse strand amplification bias were 
a result of reads mapping mainly to a single DNA strand and though rare were eliminated by 
determining the rate of variants as a function of this strand bias effect.  
 
We scanned for dose-dependent, heterozygous and homozygous mutations because these may 
be haplosufficient, and proteins associated with resistance may form heterodi- or multi-mers 
(Paape and Aebischer, 2011). Chromosome copy number variation and scans for large CNVs 
and episomes were performed based on per cell read depth to reflect gene dosage as outlined 
previously (Downing et al., 2011). Using the difference in read-depth allele frequencies 
between steps, 53% of valid SNPs were homozygous (a read-depth frequency > 0.95). This 
approach detected heterozygous alleles on trisomic and tetrasomic chromosomes where 
differences in the allele frequencies based on the reads can be more challenging to detect if 
present on a single chromosome only. Multiple complementary variant-calling tools were 
used to discover SNPs and infer genotypes: Samtools pileup v0.1.11 (Li et al., 2009), 
Samtools mpileup v0.1.18, FreeBayes (Garrison and Marth, 2012), GATK (McKenna et al., 
2010) and Cortex (Iqbal et al.,  2012). SNPs associated with 74 µM MIL resistance were 
present in all technical replicates.  
  
Candidate MIL-R mutations were identified using a deep sequencing approach using 
promastigote parasites from each selection step after cloning of the parental parasite, i.e. after 
adaption to 3, 6, 12, 35, 49, 61and 74 µM MIL. Four (Sb-S MIL-R clone 8) and six (Sb-R 
MIL-R clone 9) replicates were sequenced to verify the mutations present in the MIL-R 
parasites. We also determined the effect of removing drug pressure on the genotype of the 
Sb-S and Sb-R MIL-R cloned parasites, by maintaining them for two weeks without drug 
pressure (74+0 µM MIL). WT parasites with the same passage number were sequenced at the 
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 same time as the corresponding MIL-R parasites to ensure that polymorphisms associated 
with long-term passaging were omitted from drug association. Chromosome copy number 
(somy), local gene copy number variation (CNV) including extra-chromosomal segments 
such as episomes, single nucleotide polymorphisms (SNPs) and indels were examined at each 
experimental stage. Mutations altering the amino acid code are more likely to have a 
pronounced positive or negative effect on protein function, and changes unique to the MIL-
resistant clones must be either beneficial or neutral (Weinreich et al., 2006). Consequently, 
nonsynonymous mutations distinguishing MIL-R from WT consistent across each step of the 
selection processes were more likely to be truly implicated in MIL resistance.  
 
Statistical inference of the selective benefit of resistance mutations 
A likelihood framework was used to evaluate the mean role of selection acting upon genetic 
variants within the population (Illingworth and Mustonen, 2012), including both mutation 
frequencies and somy variants.  Given a set of observed data O, parameters within a variety 
of models M were optimised in order to maximise the likelihood L(O|M).  Different models 
described different patterns of evolution under neutrality, or selection for specific genetic 
variants.  The Bayesian Information Criterion (BIC) was used to distinguish between models 
of differing complexity, minimising the value: 
BIC = -2 log L(O|M) + k log n 
where n is the number of data points in the model and k is the number of model parameters.  
Observed allele frequencies were modelled using a multinomial likelihood function, while 
observed changes in chromosomal copy number were modelled using a double Poisson 
likelihood function. Full details of the model are given in Text S4. 
 
Prediction of protein mutation amino acid properties, position and functional impact 
The biochemical and structural properties of proteins were examined using amino acid 
hydrophobicity to determine the transmembrane (TM) portions of the protein using Bioedit 
v7.0.9.1, ProtScale (Gasteiger et al., 2005) and the Membrane Protein Explorer (MPEx v3.2, 
Snider et al., 2009). Surface accessibility and secondary structure were used to predict 
whether mutant amino acids were more likely to be internal or external in the protein, and if 
they were part of alpha-helix, beta-sheet or coil structures (NetSurfP, Petersen et al., 2009). 
Protein function impacts were predicted with Polyphen-2 v2.2.2 (Adzhubei et al., 2010), 
SNAP (Bromberg and Rost, 2007) and SIFT (Kumar et al., 2009). 
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 PCR studies  
PCR studies were completed using genomic DNA or cDNA prepared from RNA, both 
isolated using L. donovani promastigotes.  Genomic DNA was prepared using the DNeasy 
Blood & Tissue kit and RNA was isolated using the RNeasy Mini Kit.  Complementary DNA 
was synthesised from 2 µg of RNA, using 1 µl of Random Primers diluted with molecular 
grade water to give final volume of 15 µl.  The mixture was incubated at 65°C for 5 minutes 
and samples were then left at room temperature for 10 minutes before adding 2 µl of 10X 
Affinity script buffer, 2µl of 100 mM DDT, 0.8µl of 100mM deoxynucleotide triphosphate 
(dNTP) mix and 1µl of RT enzyme to a final volume of 20 µl. Samples were incubated at 
25°C for 10 minutes, followed by 55°C for 1 hour, and then heated at 70°C for 15 minutes.  
PCR studies with primers specific for L. donovani LdMT gene (LdMT-Forward:  
5’-CAAGTGCCTTTCCACCAGAATC-3’,LdMT-Reverese: 5’-
CTCACCTTTTTGAACTCCAAC AGG-3) and alpha-tubulin gene (AlphaTubulin-Forward: 
5’-AGCTGTCCGTCGCGGACATCA CGAACTCGGTGTTT-3’, AlphaTubulin-Reverse:5’-
CGAACTGAATTGTGCGCTTCGTCT TGATCGTCGCAAT-3’). Each PCR reaction 
contained 2 µl MyTaq DNA Polymerase, 10 µl 5x Reaction Buffer, 25 pmol each of forward 
and reverse primers, 2 µl of DNA and made to a final volume of 30 µl with molecular grade 
water. PCR conditions were as follows: Denaturation at 94˚C for 3 minutes, 35 cycles of 
94˚C for 30 seconds, annealing 64˚C for 45 seconds and extension at 72˚C for 1 minute. Final 
extension was carried out at 72˚C for 10 minutes. PCR products were separated by gel 
electrophoresis and the products visualised under UV light and a digital image of the results 
obtained.    
  
Quantitative RT-PCR reactions were carried out in a final volume of 12.5µl, using 6.25µl 
SYBR green, 1 µl template cDNA, 25pmol of forward and reverse primers (as above) and 
molecular grade water. In RT-PCR reactions the following conditions were used:  
denaturation at 95˚C for 10 minutes; 40 cycles of the following steps: 95˚C for 30 seconds, 
63˚C for 45 seconds and extension at 72˚C for 1 minute;  and a final cycle of 95°C for 30 
seconds and 55˚C for 30 seconds. All samples were carried out in duplicate. Gene expression 
was calculated using the -∆∆CT method (Livak and Schmittgen, 2001) method. The 
housekeeping gene α-tubulin was used as a comparison for expression levels. 
 
Promastigote inhibition studies 
The effects of MIL on the growth of promastigotes were tested using a colorimetric-based 
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 assay using resazurin. Parasites were added to the wells of a 96 well tissue culture plate at a 
concentration of 5x105 parasites/ well and grown in the presence of medium alone (controls) 
or medium containing various concentrations of MIL (3-785 µM, n = 6/treatment). Plates 
were incubated for 72 hours at 27°C. and then 20µl resazurin solution (0.0125% w/v PBS pH 
7.4) was then added to samples and the samples were incubated for a further 18 hours at 
27°C. The absorbance of samples at 550-590 nm was determined using Softmax Pro 2.0 
software. The effect of drug treatment on cell viability was determined by calculating the 
percentage suppression in cell growth for drug treated samples compared with the mean 
control value (n = 6/treatment).  The mean suppression/treatment was used to determine the 
IC50 for a particular formulation using Grafit
® 5 software.  
 
MIL uptake studies  
To quantify the uptake of MIL by WT and MIL-R parasites, 5ml cultures of parasites at day 4 
of growth were pelleted, resuspended in 5 ml medium containing 7µM MIL, and the resulting 
suspension was transferred to a new tissue culture flask. Flasks were quenched at time 0, 30, 
60 and 120 minutes post exposure to MIL and 4x107 parasites were aliquoted into pre-chilled 
eppendorfs, sitting on ice. Lipid extraction was then carried out on these samples as described 
above. A calibration curve was produced by spiking samples of the extraction solvent with 
MIL standards at  0.24, 0.72, 2.4, 7.2 and 14.4 mM. Linear regression was used to fit a 
standard curve for the AUC of the MIL peak from the standards (correlation coefficent > 
0.97), and this data was used to determine the MIL present in parasites at time of quenching.  
 
Macrophage studies 
Peritoneal macrophages, harvested from mice 72 hours after intraperitoneal injection of 
starch solution (3% w/v PBS pH 7.4), using the method described by Carter et al. (2005). 
Cells were infected using a host: parasite ratio of 20:1. The effect of treatment on parasite 
survival was determined as the mean percentage suppression in the percentage of cells 
infected and the number of parasites/ host cell/for each treatment (n = 4/treatment) by 
comparing each experimental value with the relevant mean control value.   
 
Statistical analysis of data 
The effect of drug treatment on cell proliferation in in vitro drug studies were analysed using 
a Mann Whitney U test for comparing two treatments or a Kruskal Wallis test followed by 
Dunns ad hoc test for statistical differences between three or more treatments (Statview® 
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 v5.0.1). Lipidomic and metabolomic data which compared WT with WT or WT with the  
corresponding MIL-R were analysed using a Mann Whitney U-test or a Student’s t-test where  
the p-values were corrected for multiple testing using the Benjamini-Hochberg method using  
R. The null hypothesis was not accepted if the adjusted p < 0.05.    
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 Table 1.  Summary of the genomic differences observed between Sb-S and Sb-R strains 
during the selection of MIL-resistance. Somy values are rounded to the nearest unit. 
 
Standing variation at outset Somy
1
 SNPs
2
 CNVs
3
 Indels
4
 
WT Sb-S vs WT Sb-R differences 8 127 16 51 
Above affecting amino acids 
 
33 13 33 
Effect of MIL on above differences Yes in 5/8 none none None 
     
New mutations during MIL-R Somy
1
 SNPs
5
 CNVs
6
 Indels 
Identical in Sb-S and Sb-R7 
Lower 
chr13 
none none None 
At same gene in Sb-S and Sb-R 
 
A691P in Sb-S, 
E197D in Sb-R 
∆LdMT 
in Sb-S 
None 
Unique to Sb-S 2 1 hom8 + 17 het 
8 (8 
CDS) 
None 
Unique to Sb-R 4 6 hom9 + 7 het 
8 (298 
CDS) 
None 
 
For full data see Tables: 1S2, 2S3 and S4A, 3S4B, 4S4C, 5S7 and S8, and 6S10. 7 Chr8 and 
chr33 also had reduced copy numbers. 8 A691P. 9 Includes E197D. 
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 Table 2.  Summary of the metabolic and lipidomic differences observed between Sb-S and 
Sb-R strains during the selection of MIL-resistance.  
 
Standing variation at outset Metabolites
1
 LPC
2
 PC
2
 
WT Sb-S vs WT Sb-R differences 14 3 18 
Effect of MIL on above differences N/A N/A 2 inc. In Sb-S MIL-R 
    
New changes during MIL-R Metabolites
3
 LPC
4
 PC
5
 
Identical in Sb-S and Sb-R 8 0 0 
Unique to Sb-S 15 4 11 
Unique to Sb-R 4 5 10 
 
 
For full data see Tables: 1S5, 2S6, 3S11, 4S12, 5S13.  
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 Table 3.  The effect of MIL selection on the MIL IC50 values of WT, MIL adapted parent and 
clones derived from the MIL-R parent for Sb-S and Sb-R L. donovani strains. 
 
Parasite Mean IC50 value  
(µM ± SE) 
N MIL-R/WT 
IC50 ratio 
Promastigotes    
WT Sb-S 
Sb-S MIL-R 74 µM parent 
Sb-S MIL-R 74 µM clone 2 
Sb-S MIL-R 74 µM clone 3 
Sb-S MIL-R 74 µM clone 6 
Sb-S MIL-R 74 µM clone 8 
13 ± 0.2 
371 ± 15  
165 ± 37 
164 ± 1 
185 ± 19 
254  
2 
2 
2 
2 
2 
1 
 
28.1 
12.5 
12.4 
14.0 
19.2 
WT Sb-R   
Sb-R  MIL-R 74 µM parent 
Sb-R  MIL-R 74 µM clone 3 
Sb-R  MIL-R 74 µM clone 6 
Sb-R  MIL-R 74 µM clone 9 
6.2 
357 ± 3 
282 ± 1 
281 ± 1 
294 ± 6 
1 
2 
1 
1 
2 
 
57.9 
45.5 
45.8 
47.4 
Intracellular amastigote    
WT Sb-S  
Sb-S MIL-R 3 µM 
Sb-S MIL-R 6 µM 
Sb-S MIL-R 12.2 µM 
Sb-S MIL-R 49.2 µM 
Sb-S MIL-R 74 µM parent 
Sb-S MIL-R 74 µM clone 8 
3 ± 1 
1 
2 
14 
47 
44 ± 13 
46 ± 18 
6 
1 
1 
1 
1 
2 
2 
 
 
 
4.7 
16.1 
15.1 
15.3 
WT Sb-R   
Sb-R MIL-R 3 µM 
Sb-R MIL-R 6 µM 
Sb-R MIL-R 12.2 µM 
Sb-R MIL-R 49.2 µM 
Sb-R MIL-R 74 µM parent  
Sb-R MIL-R 74 µM clone 9  
Sb-R MIL-R 74 µM clone 9 no drug 
3 ± 1 
0.2 
2 
9 
33 
35 ± 8 
53 ± 1 
35 ± 1 
6 
1 
1 
2 
1 
2 
2 
2 
 
 
 
3.3 
12.7 
13.4 
17.6 
13.5 
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 Fig. 1 The effect of drug treatment on the survival of promastigotes (A, B) or intracellular 
amastigotes (C, D) of L. donovani parasites treated with MIL (A, B, C) or sodium 
stibogluconate (SSG, D). Promastigotes of the Sb-S or Sb-S MIL-R clone 8 strain were 
grown in the presence of medium alone (controls) or different concentrations of MIL (n = 
6/treatment). Cytotoxicity was assessed by determining the mean suppression of drug treated 
samples compared to the relevant control (A, B). In amastigotes studies, macrophages were 
infected with the relevant parasite (C, Sb-R WT or Sb-R MIL-R clone 9, D; Sb-S WT or Sb-S 
MIL-R clone 8) and then incubated with medium alone (controls) or medium containing MIL 
(C) or SSG (D, n = 4/treatment). After 72 hours the percentage of cells infected was assessed 
and the mean suppression in parasite numbers compared to the relevant control. Data is 
representative of a minimum of two experiments. *p < 0.05, ***p < 0.001 compared to 
relevant control.  
 
Fig. 2. The genetic mechanisms responsible for reducing the amount of LdMT 
transporter protein in parasites  (A) Somy changes observed for Sb-R WT (top) and Sb-S 
WT (bottom) during MIL exposure (x-axis) ranging from 0 (blue) to 74 µM (shades of red). 
The WT (0 uM) and fully resistant stages (74 µM) were completed with one and five 
replicates for Sb-R (respectively) and with three replicates for Sb-S. For Sb-R, a resistant 
sample was passaged with (74+74) and without the drug (74+0, with one replicate). For Sb-S, 
a resistant sample was passaged without the drug too (74+0). The blue-green-beige shading 
indicates the ploidy state: 1 is disomic, 1.5 is trisomic, and 2 is tetrasomic. Chromosome 13 
was downregulated in both strains, Chr33 was only in the Sb-S one. (B). The routes to 
reducing LdMT dosage for Sb-S WT during MIL exposure (x-axis) ranging from 0 to 74 µM: 
an initial decrease in dose though aneuploidy at 3 µM, a deletion also at 3 µM, and then 
A691P at 6 µM. The y-axis indicates the alleles’ copy number within the Sb-S population 
assuming one LdMT copy represents the expected disomic state. Black indicates the WT 
state (A691). At 3 µM MIL, the chromosome copy number decreased from 2.80 to 0.93, and 
a deletion occurred encompassing LdMT that continued to increase in frequency until 35 µM. 
At 12 µM MIL, P691 occurred and rose in level until the final step at 61 µM. (C) 
Localisation of the LdMT deletion in the Sb-R MIL-R strain; upper part, sequencing read 
depth over the region; lower part, physical map of the LdMT locus: coordinates were given in 
a draft reference based on Pacbio sequencing, since this region contains gaps in the current 
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 reference and was not properly assembled. The two black arrows indicate the localization of 
the two 444 bp direct repeats at the deletion boundaries. 
 
Fig.3 A comparison of MIL uptake in MIL-R (Sb-S MIL-R clone 8, Sb-R MIL-R clone 9) 
and their corresponding WT strains (Sb-S and Sb-R) of L. donovani. Promastigotes were 
cultured in HOMEM medium with and without 7 µM MIL for 0-120 mins.  Samples were 
quenched and lipid extraction carried out using promastigotes samples (4x107, n = 
4/treatment). The amount of MIL present (µg/ml) was determined using a calibration curve 
prepared using MIL standards.  
 
Fig. 4 Diagrammatic representation of the Kennedy pathway metabolites altered in the MIL-
R parasites of Sb-S (A) and Sb-R (B) compared to their corresponding WT. A blue circle 
denotes a significant down regulation (p < 0.05) of the metabolite in the MIL-R strain 
compared to its WT. A red circle denotes a significant up regulation (p < 0.05) in the MIL-R 
compared to WT. Key: a-chol, acytelcholine; g-3-pchol, glycero-3-phosphocholine; chol, 
choline; CDP-choline, cytidine diphosphate-choline; PC, phosphatidylcholine; p-d-eth, 
phosphodimethylethanolamine; N-meth-eth-p, N-methylethanolamine phosphate; eth, 
ethanolamine; eth-p, ethanolamine phosphate; CDP-eth, cytidine diphosphate-ethanolamine; 
PE, phosphodimethyethanolamine. 
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Fig. 2. The genetic mechanisms responsible for reducing the amount of LdMT transporter protein in 
parasites  (A) Somy changes observed for Sb-R WT (top) and Sb-S WT (bottom) during MIL exposure (x-
axis) ranging from 0 (blue) to 74 µM (shades of red). The WT (0 uM) and fully resistant stages (74 µM) were 
completed with one and five replicates for Sb-R (respectively) and with three replicates for Sb-S. For Sb-R, 
a resistant sample was passaged with (74+74) and without the drug (74+0, with one replicate). For Sb-S, a 
resistant sample was passaged without the drug too (74+0). The blue-green-beige shading indicates the 
ploidy state: 1 is disomic, 1.5 is trisomic, and 2 is tetrasomic. Chromosome 13 was downregulated in both 
strains, Chr33 was only in the Sb-S one. (B). The routes to reducing LdMT dosage for Sb-S WT during MIL 
exposure (x-axis) ranging from 0 to 74 µM: an initial decrease in dose though aneuploidy at 3 µM, a deletion 
also at 3 µM, and then A691P at 6 µM. The y-axis indicates the alleles’ copy number within the Sb-S 
population assuming one LdMT copy represents the expected disomic state. Black indicates the WT state 
(A691). At 3 µM MIL, the chromosome copy number decreased from 2.80 to 0.93, and a deletion occurred 
encompassing LdMT that continued to increase in frequency until 35 µM. At 12 µM MIL, P691 occurred and 
rose in level until the final step at 61 µM. (C) Localisation of the LdMT deletion in the Sb-R MIL-R strain; 
upper part, sequencing read depth over the region; lower part, physical map of the LdMT locus: coordinates 
were given in a draft reference based on Pacbio sequencing, since this region contains gaps in the current 
reference and was not properly assembled. The two black arrows indicate the localization of the two 444 bp 
direct repeats at the deletion boundaries.  
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Fig.3 A comparison of MIL uptake in MIL-R (Sb-S MIL-R clone 8, Sb-R MIL-R clone 9) and their 
corresponding WT strains (Sb-S and Sb-R) of L. donovani. Promastigotes were cultured in HOMEM medium 
with and without 7 µM MIL for 0-120 mins.  Samples were quenched and lipid extraction carried out using 
promastigotes samples (4x107, n = 4/treatment). The amount of MIL present (µg/ml) was determined using 
a calibration curve prepared using MIL standards.  
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Fig. 4 Diagrammatic representation of the Kennedy pathway metabolites altered in the MIL-R parasites of 
Sb-S (A) and Sb-R (B) compared to their corresponding WT. A blue circle denotes a significant down 
regulation (p < 0.05) of the metabolite in the MIL-R strain compared to its WT. A red circle denotes a 
significant up regulation (p < 0.05) in the MIL-R compared to WT. Key: a-chol, acytelcholine; g-3-pchol, 
glycero-3-phosphocholine; chol, choline; CDP-choline, cytidine diphosphate-choline; PC, 
phosphatidylcholine; p-d-eth, phosphodimethylethanolamine; N-meth-eth-p, N-methylethanolamine 
phosphate; eth, ethanolamine; eth-p, ethanolamine phosphate; CDP-eth, cytidine diphosphate-
ethanolamine; PE, phosphodimethyethanolamine.  
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This study provides an integrated analysis of genomic and metabolomic data during 
selection of MIL resistance in two L. donovani strains with different inherent 
antimonial sensitivities.  
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